Business Standard

Thursday, December 19, 2024 | 04:35 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Why an angry China is behind Pakistan's revamped counter-terror campaign

Pakistan's government recently approved a 'reinvigorated and re-energised' national counter-terrorism campaign, called 'Operation Azm-i-Istehkam'

jobs, job opening, hiring, job

Photo: Bloomberg

Aashish Chaudhry New Delhi

Listen to This Article

China's reported reluctance to invest in new China–Pakistan Economic Corridor (CPEC) schemes, largely driven by Beijing's concerns about the security of its citizens and assets in Pakistan, appears to have finally forced the Pakistani government's hand, with Islamabad on Saturday approving a reinvigorated national counter-terrorism campaign.

Days after Pakistani publication Dawn reported that the Pakistani government had approved a "reinvigorated and re-energised" national counter-terrorism campaign, called 'Operation Azm-i-Istehkam', an editorial published by it hinted at the real reason behind the move: China's (security) concerns "should not be taken lightly by Pakistan's ruling elite", especially when the country "needs all the foreign investment it can get".
 

The Reserve Bank of India (RBI) has inducted an additional director on the board of Bandhan Bank, weeks before the current managing director (MD) & chief executive officer (CEO) Chandra Shekhar Ghosh’s retirement.

Arun Kumar Singh, former chief general manager (CGM) of RBI, will be on the board for one year, from June 24, 2024, to June 23, 2025, the Kolkata-based bank said in a late evening communication to the stock exchanges.

accompanied by a 14 per cent increase in margin.

For the full fiscal year 2023-24, the net profit surged by 82.4 per cent to Rs 1,795.7 crore, while revenue from operations saw a 9.1 per cent uptick, reaching Rs 12,662.5 crore.

Additionally, the pharmaceutical giant proposed a final dividend of Rs 5 per equity share with a face value of Rs 2 for FY24.

The brokerage stance after Alkem Labs Q4 show remained mixed as some gave it a neutral rating on the stock, while others gave it an underperforming tag. 
According to analysts at Nuvama Research, Alkem’s Q4FY24 revenue and Ebitda missed its  consensus estimates by 8 to 9 per cent  each while PAT missed estimates by 13 per cent. Domestic business was also flat YoY due to high base and low seasonality

 index will need to cross this, in order to open the doors for further upside in the year ahead.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 25 2024 | 7:57 PM IST

Explore News Home